Michael Amoroso is the CEO of Precision BioSciences, a biotechnology company focused on making a positive impact in the healthcare landscape. With an Executive M.B.A. from NYU's Stern School and a B.A. in Biological Sciences, Amoroso brings a robust academic...

Michael Amoroso is the CEO of Precision BioSciences, a biotechnology company focused on making a positive impact in the healthcare landscape. With an Executive M.B.A. from NYU's Stern School and a B.A. in Biological Sciences, Amoroso brings a robust academic foundation to his role. His career includes a stint at Abeona Therapeutics before joining Precision BioSciences in October 2021. Under his leadership, the company's compensation structure focuses on aligning executive pay with company performance, balancing salary and bonuses based on achievement metrics. In 2023, Amoroso's total compensation reached over $1 million, largely influenced by his strategic decisions that have driven the company forward. Notably, he has seen significant fluctuations in his insider trading activities, peaking in early 2024 when he sold shares valued at over $240,000, signaling a confident stance in his company's future. His journey reflects a blend of strategic insight and deep sector expertise, positioning him as a pivotal figure in the biotechnology arena.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

P

Michael Amoroso

CEO of Precision BioSciences, Inc.

Field of Expertise

Healthcare & Life Sciences - Biotechnology

Sector of Economy

Healthcare

CEO of Precision BioSciences, Inc. for

1 year 4 months (Jan 2024 - Present)

Previous Experience

Unknown

Rivals

Competitors/colleagues of Michael Amoroso

Holdings

See how much did Michael Amoroso make over time.

Michael Amoroso's insider trading shows a fluctuating pattern with significant activity in 2024. He began selling shares of Precision BioSciences in late 2022. His transactions ranged from smaller amounts, like $15K, to much larger sales, hitting peaks of over $240K....

Michael Amoroso's insider trading shows a fluctuating pattern with significant activity in 2024. He began selling shares of Precision BioSciences in late 2022. His transactions ranged from smaller amounts, like $15K, to much larger sales, hitting peaks of over $240K. For instance, in June 2024, he sold approximately $244.98K in shares. This consistent trading indicates his active management of holdings as he navigates company growth. As of now, his wealth is increasingly tied to the company's performance, reflecting a high level of confidence in Precision's future prospects and growth potential.

Mar 17, 2025

A

shares

ABEO @ $5.30

D

shares

DTIL @ $5.05

Total Stock Sold

$8.37M

DTIL

$4.93M

53,020.667 DTIL shares

ABEO

$3.43M

11,075.72 ABEO shares

What if they kept their stock?

If Michael Amoroso didn't sell their stock, today they would have:
Extra DTIL53,020.667 shares worth $11.91M and ABEO11,075.72 shares worth $719.92K.
This is 50.99% and $4.27M more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Michael Amoroso.

DTIL

$5.36K

DTIL at $5.56/share

Mar 21, 2025

Sale

ABEO

36,101 shares

ABEO

Jan 31, 2025

Received

DTIL

$172.03K

DTIL at $4.67/share

Jan 20, 2025

Sale

DTIL

$24.67K

DTIL at $8.19/share

Nov 2, 2024

Sale

ABEO

11,797 shares

ABEO

Aug 26, 2024

Received

ABEO

23,611 shares

ABEO

Jul 8, 2024

Received

DTIL

$100.01K

DTIL at $12.00/share

May 8, 2024

Received

DTIL

$15.75K

DTIL at $10.32/share

May 1, 2024

Sale

DTIL

$49.46K

DTIL at $0.36/share

Jan 20, 2024

Sale

DTIL

$50.01K

DTIL at $0.40/share

Nov 2, 2023

Sale

Compensation History

See how much did Michael Amoroso make over time.

In 2023, Michael Amoroso's total compensation was over $1 million. His salary took up a big part of that, adding up to around $629K. He also received a bonus of $381K based on the company's performance objectives. Interestingly, while his base pay is solid, most of his compensation stems from performance-based bonuses. Over the years, his pay has shown a noticeable increase, rising from about $605K in 2022 to over $1 million in 2023, reflecting his success and the company's growth trajectory. The structure of his pay is designed to encourage alignment with company goals, pushing for better results. Overall, Amoroso's compensation strategy is straightforward: perform well, and the rewards follow.

Year

2023

Total Compensation

$1.07M

Salary

$629.92K

Board Justification

The compensation philosophy of the company for the CEO in 2023 is designed to align with company performance, peer benchmarking, and retention strategies.

Bonus

$381.00K

Board Justification

The amounts reported for 2023 represent bonuses based upon our Board’s assessment of the achievement of company and individual performance objectives for 2023, which were paid in February 2024.

Other

$60.39K

Board Justification

The amount reported represents 401(k) matching contributions of $13,800, temporary housing and travel reimbursements of $41,399 and $5,189 in supplemental disability insurance premiums available to certain executives.

Restricted Stock

$0.00(0 common stock)

Board Justification

No stock was reported as vested in 2023.

Performance Metrics

The performance metrics of the company for the CEO that determines the compensation in 2023 are based on the achievement of company goals.